(Q44506008)

3 December 2017

title

Foggy visual field defect (English)

1 reference

3 December 2017

Rod Foroozan

1

1 reference

3 December 2017

Lawrence M Buono

series ordinal

2

1 reference

3 December 2017

publication date

1 July 2003

1 reference

3 December 2017

published in

Survey of Ophthalmology

1 reference

3 December 2017

volume

48

1 reference

3 December 2017

issue

4

1 reference

3 December 2017

page(s)

447-451

1 reference

A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2803%2900051-1

7 January 2021

Topiramate as an inhibitor of carbonic anhydrase isoenzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2803%2900051-1

7 January 2021

Ictal amaurosis: MRI, EEG, and clinical features

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2803%2900051-1

7 January 2021

Multifocal ERG and full-field ERG in patients on long-term vigabatrin medication

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2803%2900051-1

7 January 2021

A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2803%2900051-1

7 January 2021

Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2803%2900051-1

7 January 2021

Effects of topiramate on cognitive function

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2803%2900051-1

7 January 2021

Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2803%2900051-1

7 January 2021

Visual field defect associated with vigabatrin: observational cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2803%2900051-1

7 January 2021

10.1016/S0039-6257(03)00051-1

Identifiers

DOI

1 reference

3 December 2017

1 reference